We used the Capan-2 pancreatic ductal adenocarcinoma (PDAC) cell line, which expresses high levels of cell-surface mucins, including MUC1 (Supplementary Fig. 1b), as target tumor cells. This evidence concerns the gene MUC1 and pancreatic ductal adenocarcinoma.